GenScript Call for Corporate Innovation Proposals

First Page		Document Content
Genetic engineering Biology CRISPR Cas9 International Genetically Engineered Machine Editas Medicine		GenScript Call for Corporate Innovation Proposals Add to Reading List Source URL: 2016.igem.org Download Document from Source Website File Size: 100,00 KB Share Document on Facebook

	CDKL5 Program of Excellence Pilot Grant Program Application Title: Development of TALE and CRISPR/Cas9 as a putative therapy for treatment or correction of genetically linked CDKL5 Deficiency PI: Jan Nolta, PhD Instituti DocID: 1vfRI - View Document
	Chromosomal deletions using CRISPR-Cas9 gene editing toolkit DocID: 1uE9h - View Document
	Articles DOI: s41564A CRISPR–Cas9-based gene drive platform for genetic interaction analysis in Candida albicans Rebecca S. Shapiro1,2,3, Alejandro Chavez3,4,5,11, Caroline B. M. Porter1,2, Meagan H DocID: 1uyzD - View Document
	Why we decided that some CRISPR-Cas9 gene-edited plants are not regulated by the GMO-directive DocID: 1ubmi - View Document
	Form to Request Design, Generation, and Injection of TAL Effector Nucleases (TALens)/ or Design, Generation, and Injection of Cas9 nucleases (CRISPR/Cas) For questions or additional information please don’t hesitate t DocID: 1u2J2 - View Document